Department of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
One Medical Center Dr.
Lebanon, NH 03756
Mark A. Cervinski, PhD
Telephone: 603 650 7114
Fax: 603 650 4845
Faculty and Research Interests
|Mark A. Cervinski, PhD, DABCC (CC)||General clinical chemistry, test utilization, based quality control (moving averages), toxicology|
|Lynn A. Brunelle, PhD DABCC (CC)||Toxicology, mass spectrometry, point-of-care testing, laboratory operations|
|K. Aaron Geno, PhD DABCC (CC)||General clinical chemistry, R programming language, endocrinology, mass spectrometry, test utilization|
|Gregory J. Tsongalis, PhD, ABB (HCLD, CC)||Molecular diagnostics, cancer biology and global health|
|Joel A. Lefferts, PhD, ABB (HCLD)||Molecular diagnostics|
|Mary Beth P. Dinulos, MD, FACMG||Clinical genetics, test utilization|
Level(s) of training: Postdoctoral
Number of positions available per year: 1
Duration of program: 2 years
Approximate annual salary or stipend: Equal to PGY-1 Pathology Residency Salary
Source of funding: Departmental Funding
Current number of trainees: 1
Number of past graduates (over last 10 years): 7
Prerequisites: PhD, MD, or MD/PhD. PhD applicants must have earned their doctoral degree in chemistry, biology, molecular biology, pharmacology, toxicology, cell biology or other basic science degree from an accredited university. All applicants must meet the minimum 30 credit hours (or the equivalent) in undergraduate or graduate level chemistry or biochemistry courses in order to qualify for the ABCC Board examination.
Applicants must submit:
- Letter of interest explaining their interested in the field
- Up-to-date curriculum vitae
- Three letters of recommendation
Submit the required materials to the firstname.lastname@example.org email address.
Applicants accepted for on-site interviews must also be able to provide official transcripts that demonstrate completion of 30 credit hours in chemistry.
Applications for the July 2024 start date are reviewed as they are received, until the position is filled. Applications missing any of the required components will not be considered until all materials are received.
ComACC accredited the clinical chemistry fellowship program at Dartmouth-Hitchcock Medical Center and the Geisel School of Medicine in 2016. The program provides the fellow with diverse exposures to clinical chemistry and laboratory medicine. The program includes direct involvement in the operations of a fully automated clinical chemistry laboratory performing approximately 5.5 million tests annually.
In addition to routine chemistry, the laboratory automation system includes testing for endocrinology, immunology, infectious disease serology and urine drug screening. The fellow also receives training in the on-site special chemistry laboratory performing IgE allergy testing, celiac disease serology, autoimmune testing, and LC-MS/MS testing for immunosuppressant drugs and urine opioids.
The clinical chemistry service also has direct oversight of three stand-alone laboratories that provide general clinical chemistry, coagulation, hematology and urinalysis testing for three large physician practices in southern New Hampshire.
The training program also offers fellow opportunities to participate in dynamic molecular pathology and translational research projects that enhance training by providing access to cutting edge molecular testing. The program at DHMC is also activity engaged in test utilization management including the participation of a Medical Geneticist that contribute to the fellow’s training.
The program faculty are active within the Northeast ADLM section and routinely attend the routinely scheduled meetings in the Boston area. Fellows within the training program are strongly encouraged to attend these educational and networking events.
Fellows are provided with a permanent desk space and desktop computer in the resident/fellow workroom for the duration of their training. Fellows are provided with a competitive travel budget to support their attendance of the ADLM annual scientific meeting and other relevant meetings.
Completion of the two-year fellowship program provides the fellow with in depth experiences in clinical laboratory medicine and provides them with the prerequisites to qualify for board eligibility from the American Board of Clinical Chemistry.